MedicineApril 24, 2019
We Need New Ideas for Fighting Alzheimer’s
Treatments based on the “amyloid hypothesis” have failed; it’s time to focus on inflammation instead
Stories by RJ Tesi
RJ Tesi, MD, is CEO and co-founder of INmune Bio (NASDAQ: INMB), a publicly traded, clinical-stage biotechnology company developing therapies that target the innate immune system to fight disease.